No market release is inexcusable. Ready to go as a commercial product subject to reg approval is a major milestone.
They have just told a room full of experts that they are on the verge of greatness but not the market. Have they not heard of listing rule 3.1???
Here is more. Written by the Robert A. Harrington. Just has a small role - Chair, Department of Medicine, Stanford University. (3rd best uni in the world)
https://www.healio.com/news/cardiology/20220828/ai-decisionsupport-tool-accurately-identifies-aortic-stenosis-with-poor-survival-odds
European Society of Cardiology Conference - No announcement so here are the findings., page-5
Add EIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $88.71M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 17.5¢ | 16.5¢ | $74.22K | 430.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 199186 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 52480 | 3 |
View Market Depth
| Last trade - 16.10pm 08/07/2024 (20 minute delay) ? |
| EIQ (ASX) Chart |